Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?


Paydas S.

ANNALS OF ONCOLOGY, cilt.27, ss.1650-1651, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 27 Konu: 8
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1093/annonc/mdw193
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Sayfa Sayıları: ss.1650-1651

Özet

Granulomatous reaction developing after immunotherapy must not be named as sarcoidosis, post-immunotherapy granulomatous reaction is more approprite in cases receiving immunotherapy.